GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomic Vision SA (FRA:G09) » Definitions » Net Margin %
中文

Genomic Vision (FRA:G09) Net Margin %

: -780.49% (As of Jun. 2023)
View and export this data going back to 2014. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Genomic Vision's Net Income for the six months ended in Jun. 2023 was €-6.40 Mil. Genomic Vision's Revenue for the six months ended in Jun. 2023 was €0.82 Mil. Therefore, Genomic Vision's net margin for the quarter that ended in Jun. 2023 was -780.49%.

The historical rank and industry rank for Genomic Vision's Net Margin % or its related term are showing as below:

FRA:G09' s Net Margin % Range Over the Past 10 Years
Min: -682.21   Med: -260.6   Max: -27.71
Current: -682.21


FRA:G09's Net Margin % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -11.145 vs FRA:G09: -682.21

Genomic Vision Net Margin % Historical Data

The historical data trend for Genomic Vision's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Vision Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -362.29 -205.81 -399.15 -353.72 -458.78

Genomic Vision Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -330.35 -376.98 -345.63 -572.86 -780.49

Competitive Comparison

For the Diagnostics & Research subindustry, Genomic Vision's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomic Vision Net Margin % Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Genomic Vision's Net Margin % distribution charts can be found below:

* The bar in red indicates where Genomic Vision's Net Margin % falls into.



Genomic Vision Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Genomic Vision's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-6.79/1.48
=-458.78 %

Genomic Vision's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-6.4/0.82
=-780.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomic Vision  (FRA:G09) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Genomic Vision Net Margin % Related Terms

Thank you for viewing the detailed overview of Genomic Vision's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomic Vision (FRA:G09) Business Description

Traded in Other Exchanges
N/A
Address
80-84 rue des Meuniers, Green Square, Batiment E, Bagneux, FRA, 92220
Genomic Vision SA is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics.

Genomic Vision (FRA:G09) Headlines

No Headlines